Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:41.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:23:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; the visible content and functionality of the page appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:10:22.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata to show 'Last Update Submitted that Met QC Criteria' and Revision: v3.4.0; removed the older QC label, 'No FEAR Act data' wording, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T19:22:47.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. No study details or page content were changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:26:38.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    New state-level study locations were added (California, Massachusetts, Texas), and the page revision was updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T21:40:53.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.